Ratio of Visceral to Subcutaneous Fat Area Is a Biomarker of Complicated Crohn's Disease

Clinical Gastroenterology and Hepatology

Volumn 9, Issue 8, 2011, Pages

  Erhayiem, Bara ^a   Dhingsa, Rajpal ^a   Hawkey, Christopher J ^a   Subramanian, Venkataraman ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

CT Imaging; IBD; Prognosis; TNF

Indexed keywords

ADIPONECTIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY FAT DISTRIBUTION; CLINICAL ARTICLE; CROHN DISEASE; DIGESTIVE SYSTEM FISTULA; DISEASE MARKER; FEMALE; HUMAN; INTESTINE OBSTRUCTION; INTRAABDOMINAL FAT; MALE; MESENTERIC FAT INDEX; MESENTERY; PATHOGENESIS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SUBCUTANEOUS FAT;

EID: 79960562088     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2011.05.005     Document Type: Article

References (22)

1. Crohn B.B., Ginzburg L., Oppenheimer G.D. Landmark article October 15, 1932: regional ileitis-a pathological and clinical entity. JAMA 1984, 251:73-79.
2. Desreumaux P., Ernst O., Geboes K., et al. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology 1999, 117:73-81.
3. Sheehan A.L., Warren B.F., Gear M.W., et al. Fat-wrapping in Crohn's disease: pathological basis and relevance to surgical practice. Br J Surg 1992, 79:955-958.
4. Schaffler A., Herfarth H. Creeping fat in Crohn's disease: travelling in a creeper lane of research?. Gut 2005, 54:742-744.
5. Borley N.R., Mortensen N.J., Jewell D.P., et al. The relationship between inflammatory and serosal connective tissue changes in ileal Crohn's disease: evidence for a possible causative link. J Pathol 2000, 190:196-202.
6. Breese E.J., Michie C.A., Nicholls S.W., et al. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 1994, 106:1455-1466.
7. Karmiris K., Koutroubakis I.E., Kouroumalis E.A. The emerging role of adipocytokines as inflammatory mediators in inflammatory bowel disease. Inflamm Bowel Dis 2005, 11:847-855.
8. Schaffler A., Furst A., Buchler C., et al. Secretion of RANTES (CCL5) and interleukin-10 from mesenteric adipose tissue and from creeping fat in Crohn's disease: regulation by steroid treatment. J Gastroenterol Hepatol 2006, 21:1412-1418.
9. Sjostrom L., Kvist H., Cederblad A., et al. Determination of total adipose tissue and body fat in women by computed tomography, 40K, and tritium. Am J Physiol 1986, 250:E736-E745.
10. Yoshizumi T., Nakamura T., Yamane M., et al. Abdominal fat: standardized technique for measurement at CT. Radiology 1999, 211:283-286.
11. Dusserre E., Moulin P., Vidal H. Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Biochim Biophys Acta 2000, 1500:88-96.
12. Fox C.S., Massaro J.M., Hoffmann U., et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007, 116:39-48.
13. Koda M., Senda M., Kamba M., et al. Sonographic subcutaneous and visceral fat indices represent the distribution of body fat volume. Abdom Imaging 2007, 32:387-392.
14. Silverberg M.S., Satsangi J., Ahmad T., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005, 19(Suppl A):5-36.
15. Blain A., Cattan S., Beaugerie L., et al. Crohn's disease clinical course and severity in obese patients. Clin Nutr 2002, 21:51-57.
16. Hass D.J., Brensinger C.M., Lewis J.D., et al. The impact of increased body mass index on the clinical course of Crohn's disease. Clin Gastroenterol Hepatol 2006, 4:482-488.
17. Moore L.L., Bradlee M.L., Singer M.R., et al. BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults. Int J Obes Relat Metab Disord 2004, 28:559-567.
18. Giovannucci E., Ascherio A., Rimm E.B., et al. Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med 1995, 122:327-334.
19. Moon H.G., Ju Y.T., Jeong C.Y., et al. Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann Surg Oncol 2008, 15:1918-1922.
20. Yamamoto K., Kiyohara T., Murayama Y., et al. Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn's disease. Gut 2005, 54:789-796.
21. Katznelson L., Fairfield W.P., Zeizafoun N., et al. Effects of growth hormone secretion on body composition in patients with Crohn's disease. J Clin Endocrinol Metab 2003, 88:5468-5472.
22. Katzmarzyk P.T., Bray G.A., Greenway F.L., et al. Racial differences in abdominal depot-specific adiposity in white and African American adults. Am J Clin Nutr 2010, 91:7-15.